Literature DB >> 19566080

Chemical and enzymatic stability of amino acid prodrugs containing methoxy, ethoxy and propylene glycol linkers.

Deepak Gupta1, Sheeba Varghese Gupta, Kyung-Dall Lee, Gordon L Amidon.   

Abstract

We evaluated the chemical and enzymatic stabilities of prodrugs containing methoxy, ethoxy and propylene glycol linkers in order to find a suitable linker for prodrugs of carboxylic acids with amino acids. l-Valine and l-phenylalanine prodrugs of model compounds (benzoic acid and phenyl acetic acid) containing methoxy, ethoxy and propylene glycol linkers were synthesized. The hydrolysis rate profile of each compound was studied at physiologically relevant pHs (1.2, 4, 6 and 7.4). Enzymatic hydrolysis of propylene glycol containing compounds was studied using Caco-2 homogenate as well as purified enzyme valacyclovirase. It was observed that the stability of the prodrugs increases with the linker length (propyl > ethyl > methyl). The model prodrugs were stable at acidic pH as compared to basic pH. It was observed that the prodrug with the aliphatic amino acid promoiety was more stable compared to its aromatic counterpart. The comparison between benzyl and the phenyl model compounds revealed that the amino acid side chain is significant in determining the stability of the prodrug whereas the benzyl or phenyl carboxylic acid had little or no effect on the stability. The enzymatic activation studies of propylene glycol linker prodrug in the presence of valacyclovirase and cell homogenate showed faster generation of the parent drug at pH 7.4. The half-life of prodrugs at pH 7.4 was more than 12 h, whereas in the presence of cell homogenate the half-lives were less than 1 h. Hydrolysis by Caco-2 homogenate generated the parent compound in two steps, where the prodrug was first converted to the intermediate, propylene glycol benzoate, which was then converted to the parent compound (benzoic acid). Enzymatic hydrolysis of propylene glycol containing prodrugs by valacyclovirase showed hydrolysis of the amino acid ester part to generate the propylene glycol ester of model compound (propylene glycol benzoate) as the major product. The amino acid prodrugs containing methoxy linker were the least stable while prodrugs containing propylene glycol linker were most stable. This work suggests that the propylene glycol linker is an optimal linker for amino acid prodrugs since it has good chemical stability and is enzymatically hydrolyzed to yield the parent drug. This approach can be further extended to other non-amino acid prodrugs and to provide a chemical handle to modify lead molecules containing carboxylic group(s).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19566080      PMCID: PMC3496387          DOI: 10.1021/mp900084v

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  15 in total

1.  Inhibition of intestinal metabolism of the antiviral ester prodrug bis(POC)-PMPA by nature-identical fruit extracts as a strategy to enhance its oral absorption: an in vitro study.

Authors:  J Van Gelder; P Annaert; L Naesens; E De Clercq; G Van den Mooter; R Kinget; P Augustijns
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

Review 2.  Mammalian peptide transporters as targets for drug delivery.

Authors:  Isabel Rubio-Aliaga; Hannelore Daniel
Journal:  Trends Pharmacol Sci       Date:  2002-09       Impact factor: 14.819

3.  In vitro stability and intestinal absorption characteristics of hexapeptide endothelin receptor antagonists.

Authors:  H K Han; B H Stewart; A M Doherty; W L Cody; G L Amidon
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

4.  Prodrugs of butyric acid. Novel derivatives possessing increased aqueous solubility and potential for treating cancer and blood diseases.

Authors:  A Nudelman; E Gnizi; Y Katz; R Azulai; M Cohen-Ohana; R Zhuk; S R Sampson; L Langzam; E Fibach; E Prus; V Pugach; A Rephaeli
Journal:  Eur J Med Chem       Date:  2001-01       Impact factor: 6.514

5.  Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues.

Authors:  D I Friedman; G L Amidon
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

6.  Bacampicillin: a new orally well-absorbed derivative of ampicillin.

Authors:  N O Bodin; B Ekström; U Forsgren; L P Jalar; L Magni; C H Ramsay; B Sjöberg
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

7.  Identification of a human valacyclovirase: biphenyl hydrolase-like protein as valacyclovir hydrolase.

Authors:  Insook Kim; Xiao-Yan Chu; Seonyoung Kim; Chester J Provoda; Kyung-Dall Lee; Gordon L Amidon
Journal:  J Biol Chem       Date:  2003-05-05       Impact factor: 5.157

8.  Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.

Authors:  H K Han; D M Oh; G L Amidon
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

9.  Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives.

Authors:  Takeshi Masuda; Shuku Yoshida; Masami Arai; Satoru Kaneko; Makoto Yamashita; Takeshi Honda
Journal:  Chem Pharm Bull (Tokyo)       Date:  2003-12       Impact factor: 1.645

10.  Molecular basis of prodrug activation by human valacyclovirase, an alpha-amino acid ester hydrolase.

Authors:  Longsheng Lai; Zhaohui Xu; Jiahai Zhou; Kyung-Dall Lee; Gordon L Amidon
Journal:  J Biol Chem       Date:  2008-02-05       Impact factor: 5.157

View more
  11 in total

Review 1.  Amino Acids in the Development of Prodrugs.

Authors:  Nuno Vale; Abigail Ferreira; Joana Matos; Paula Fresco; Maria João Gouveia
Journal:  Molecules       Date:  2018-09-11       Impact factor: 4.411

2.  Selection of suitable prodrug candidates for in vivo studies via in vitro studies; the correlation of prodrug stability in between cell culture homogenates and human tissue homogenates.

Authors:  Yasuhiro Tsume; Gordon L Amidon
Journal:  J Pharm Pharm Sci       Date:  2012       Impact factor: 2.327

3.  Synthesis of a long acting nanoformulated emtricitabine ProTide.

Authors:  Dhruvkumar Soni; Aditya N Bade; Nagsen Gautam; Jonathan Herskovitz; Ibrahim M Ibrahim; Nathan Smith; Melinda S Wojtkiewicz; Bhagya Laxmi Dyavar Shetty; Yazen Alnouti; JoEllyn McMillan; Howard E Gendelman; Benson J Edagwa
Journal:  Biomaterials       Date:  2019-08-20       Impact factor: 12.479

4.  Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue.

Authors:  Tuba Incecayir; Jing Sun; Yasuhiro Tsume; Hao Xu; Tomoka Gose; Takeo Nakanishi; Ikumi Tamai; John Hilfinger; Elke Lipka; Gordon L Amidon
Journal:  J Pharm Sci       Date:  2016-02       Impact factor: 3.534

5.  The achievement of mass balance by simultaneous quantification of floxuridine prodrug, floxuridine, 5-fluorouracil, 5-dihydrouracil, α-fluoro-β-ureidopropionate, α-fluoro-β-alanine using LC-MS.

Authors:  Yasuhiro Tsume; Chester J Provoda; Gordon L Amidon
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-03-05       Impact factor: 3.205

6.  Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach.

Authors:  Sheeba Varghese Gupta; Deepak Gupta; Jing Sun; Arik Dahan; Yasuhiro Tsume; John Hilfinger; Kyung-Dall Lee; Gordon L Amidon
Journal:  Mol Pharm       Date:  2011-09-22       Impact factor: 4.939

7.  Transporter-targeted lipid prodrugs of cyclic cidofovir: a potential approach for the treatment of cytomegalovirus retinitis.

Authors:  Mitan R Gokulgandhi; Megha Barot; Mahuya Bagui; Dhananjay Pal; Ashim K Mitra
Journal:  J Pharm Sci       Date:  2012-04-12       Impact factor: 3.534

8.  Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.

Authors:  Deepak Gupta; Sheeba Varghese Gupta; Arik Dahan; Yasuhiro Tsume; John Hilfinger; Kyung-Dall Lee; Gordon L Amidon
Journal:  Mol Pharm       Date:  2013-01-04       Impact factor: 4.939

9.  Current Challenges and Opportunities in Treating Glioblastoma.

Authors:  Andrea Shergalis; Armand Bankhead; Urarika Luesakul; Nongnuj Muangsin; Nouri Neamati
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

10.  A new prodrug and bioactivity evaluation of methotrexate based on Chitosan.

Authors:  Mohsin Omar Mohammed; Hameed Madlool Mohammed Alkubaisi; Nadia Qader Haj
Journal:  Heliyon       Date:  2020-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.